Magnesium and contraction of arterial smooth muscle.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects*; D001285:Atropine / Q000494:pharmacology; D001464:Barium / Q000037:antagonists & inhibitors; D001593:Benzyl Compounds / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects; D002712:Chlorides / Q000037:antagonists & inhibitors; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005029:Ethylenediamines / Q000494:pharmacology; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology*; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009129:Muscle Tonus / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D010121:Oxytocin / Q000037:antagonists & inhibitors; D010646:Phentolamine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D012702:Serotonin Antagonists; D013268:Stimulation, Chemical; D014667:Vasopressins / Q000037:antagonists & inhibitors
D001593:Benzyl Compounds; D002712:Chlorides; D005029:Ethylenediamines; D011725:Pyridines; D012702:Serotonin Antagonists; D014667:Vasopressins; D000804:Angiotensin II; D001464:Barium; D010121:Oxytocin; D001285:Atropine; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D008784:Methysergide; D004837:Epinephrine; D010646:Phentolamine